Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 20 | ECE2009 | Next issue

11th European Congress of Endocrinology

Poster Presentations

Diabetes and Cardiovascular

Previous section
Comparative Endocrinology
Table of contents
Next section
Obesity and Metabolism

ea0020p333 | Diabetes and Cardiovascular

Characterization of a young population of type 1 diabetics

ea0020p334 | Diabetes and Cardiovascular

How diabetic children’s families inject them insulin at home

ea0020p335 | Diabetes and Cardiovascular

HLA DQB1 and HLA DQA1 genotypes prevalence in children and adolescence with new-onset diabetes type 1 in the lower Silesia region

ea0020p336 | Diabetes and Cardiovascular

Comparative molecular analysis of TRAIL ligand and receptor expression profiles in cyclophosphamide versus streptozotocin-induced diabetes in non-obese diabetic (NOD) mice

ea0020p337 | Diabetes and Cardiovascular

Association of IL-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus

ea0020p338 | Diabetes and Cardiovascular

Saxagliptin added to a thiazolidinedione, metformin or a sulphonylurea improves glycaemic control in patients with inadequately controlled type 2 diabetes mellitus

ea0020p339 | Diabetes and Cardiovascular

Change of physical activity, diet habits and risk of diabetes after lifestyle intervention. Diabetes in Europe: prevention using lifestyle, physical activity, and nutritional intervention: the DePlan Project Krakow

ea0020p340 | Diabetes and Cardiovascular

Limits in using brain natriuretic peptide (BNP) as a biomarker of acute right ventricular dysfunction in pulmonary embolism

ea0020p341 | Diabetes and Cardiovascular

Determination of oxidized LDL and anti oxidized LDL antibody in patients with type 2 diabetes

ea0020p342 | Diabetes and Cardiovascular

Relationship between lipid oxidation and insulin resistance in type 2 diabetes mellitus

ea0020p343 | Diabetes and Cardiovascular

Role of soluble fas/fas ligand pathway and osteoprotegerin levels in patients with diabetic foot

ea0020p344 | Diabetes and Cardiovascular

Abstract unavailable

ea0020p345 | Diabetes and Cardiovascular

Evaluation of coronary artery disorders in diabetic patients with no or atypical cardiac symptoms

ea0020p346 | Diabetes and Cardiovascular

Impaired glucose regulation and arterial stiffness

ea0020p347 | Diabetes and Cardiovascular

Association between polymorphisms in the promoter of heme oxygenase-1 and vascular complications in type 2 diabetic patients

ea0020p348 | Diabetes and Cardiovascular

Paradoxical effects of GABA on glucose-stimulated insulin secretion from isolated islets in rat

ea0020p349 | Diabetes and Cardiovascular

Inspiratory muscle strength is correlated with carnitine levels in type 2 diabetes

ea0020p350 | Diabetes and Cardiovascular

Mildronate positively affects compensation of diabetes in streptozotocin rats and alters iNOS gene expression in rat tissues

ea0020p351 | Diabetes and Cardiovascular

Topical Atorvastatine may be beneficial in the treatment of the wounds in diabetic rats

ea0020p352 | Diabetes and Cardiovascular

Coronary heart disease risk reduction in obese patients submitted to adjustable gastric band

ea0020p353 | Diabetes and Cardiovascular

Atherogenic and anti-atherogenic risk markers in subjects with obesity and/or type 2 diabetes

ea0020p354 | Diabetes and Cardiovascular

Optimal fasting plasma glucose level for diagnosis of diabetes in a Singaporean population

ea0020p355 | Diabetes and Cardiovascular

Endogenous estrogen levels are associated with endothelial function in males independently of lipid levels

ea0020p356 | Diabetes and Cardiovascular

Glucose intolerance and risk of cardiovascular disease: results of the 7.6 year follow-up of the Tehran lipid and glucose study (TLGS)

ea0020p357 | Diabetes and Cardiovascular

Pharmacokinetics of the dipeptidyl peptidase-4 inhibitor saxagliptin in subjects with renal impairment

ea0020p358 | Diabetes and Cardiovascular

Biphasic insulin aspart 30/70 improves glycaemic control in patients with type 2 diabetes: clinical practice experience from Indian subgroup of the IMPROVE study™

ea0020p359 | Diabetes and Cardiovascular

Saxagliptin either as add-on therapy to metformin or as initial combination therapy with metformin improves glycaemic control in patients with type 2 diabetes

ea0020p360 | Diabetes and Cardiovascular

Effects of estrogen therapy on cardiovascular risk factor in transsexuals

ea0020p361 | Diabetes and Cardiovascular

Carotid intima media thickness and serum osteoprotegerin and RANKL levels in diabetic and prediabetic patients

ea0020p362 | Diabetes and Cardiovascular

Klotho gene polymorphism may be a genetic risk factor for metabolic syndrome in men

ea0020p363 | Diabetes and Cardiovascular

Chemotherapy does not influence measures of glycaemic control in non-diabetic patients affected by acute leukaemia

ea0020p364 | Diabetes and Cardiovascular

Pancreatic function in β-thalassemic patients

ea0020p365 | Diabetes and Cardiovascular

Characterization of type I interferon (IFN) mediated diabetes sparing activity

ea0020p366 | Diabetes and Cardiovascular

A comparison between adhesion molecules (as markers of inflammation) in identifying cardiovascular disease in postmenopausal women

ea0020p367 | Diabetes and Cardiovascular

The relationship between hemoglobin levels and endothelial functions in diabetes mellitus

ea0020p368 | Diabetes and Cardiovascular

Lack of association between polymorphisms at the adiponectin gene locus and type 2 diabetes as well as body mass index in Latvian population

ea0020p369 | Diabetes and Cardiovascular

Epicardial adipose tissue thickness and serum visfatin levels in patients with new diagnosed prediabetes and type 2 diabetes mellitus

ea0020p370 | Diabetes and Cardiovascular

The relationship between body mass index-left ventricle mass index-myocardial performance index in type 2 diabetes

ea0020p371 | Diabetes and Cardiovascular

Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients

ea0020p372 | Diabetes and Cardiovascular

N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with type 2 diabetes mellitus

ea0020p373 | Diabetes and Cardiovascular

Hyperhomocysteinemia may be a risk factor for diabetic foot ulcer development

ea0020p374 | Diabetes and Cardiovascular

Incidence of diabetic ketoacidosis during Ramadan fasting in Benghazi, Libya

ea0020p375 | Diabetes and Cardiovascular

ECoRI polymorphism but not XBaI polymorphism of apolipoprotein B gene is associated with carotis intima media thickness in type 2 diabetic patients

ea0020p376 | Diabetes and Cardiovascular

Insulin-loaded lipid nanospheres surfaced with polysaccharides for oral delivery

ea0020p377 | Diabetes and Cardiovascular

Influence of admission plasma glucose level on short and long-term prognosis in patients with ST-Segment elevation myocardial infarction

ea0020p378 | Diabetes and Cardiovascular

The effect of glycemic control on mean platelet volume in patients with type 2 diabetes mellitus

ea0020p379 | Diabetes and Cardiovascular

Association between APOE genotype and hsCRP in Iranian population: Tehran, lipid and glucose study

ea0020p380 | Diabetes and Cardiovascular

Ca 19-9 levels in type 2 diabetes mellitus patients

ea0020p381 | Diabetes and Cardiovascular

Plasminogen activator inhibitor 1 and atherosclerosis in diabetes mellitus type 2

ea0020p382 | Diabetes and Cardiovascular

Combined treatment in childhood diabetes could influence remission period

ea0020p383 | Diabetes and Cardiovascular

Impact of age, gender, DM duration and BMI on metabolic control of T2DM patients in Jordan

ea0020p384 | Diabetes and Cardiovascular

Retinol binding protein-4 is associated with TNF-α and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease

ea0020p385 | Diabetes and Cardiovascular

Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran Lipid and Glucose Study

ea0020p386 | Diabetes and Cardiovascular

NovoMix30® reduces hypoglycemic events with favorable weight change in poorly controlled type 2 diabetes patients: results from Indian cohort of IMPROVE Study

ea0020p387 | Diabetes and Cardiovascular

Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in diabetic foot ulcers

ea0020p388 | Diabetes and Cardiovascular

Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus

ea0020p389 | Diabetes and Cardiovascular

Prevalence of atopic profile in patients with type 1, type 2 and LADA diabetes mellitus

ea0020p390 | Diabetes and Cardiovascular

Prevalence of cardiovascular risk polymorphisms and its association with microvascular complications in an adolescent type 1 diabetes population

ea0020p391 | Diabetes and Cardiovascular

Visfatin seems not to be related in insulin resistance

ea0020p392 | Diabetes and Cardiovascular

Anthropometric determinants of adiponectin levels in obese and non obese premenopausal women

ea0020p393 | Diabetes and Cardiovascular

Is brachial artery diameter most significant determinator of the flow-mediated dilatation?

ea0020p394 | Diabetes and Cardiovascular

General and central obesity and risk of cardiovascular disease: results of the 7.6-year follow-up study in Iranian men

ea0020p395 | Diabetes and Cardiovascular

Prevalence of undiagnosed glucose intolerance changes according to age and gender in Japanese middle aged working people

ea0020p396 | Diabetes and Cardiovascular

Diabetes and obesity associated difference in aggregation platelet capacity

ea0020p397 | Diabetes and Cardiovascular

Functional balance in diabetic neuropathy

ea0020p398 | Diabetes and Cardiovascular

Terminalia bellerica (Belliric Myrobalan) stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation

ea0020p399 | Diabetes and Cardiovascular

The frequency of diabetic retinopathy and relevant factors for prediabetic subjects

ea0020p400 | Diabetes and Cardiovascular

Prognostic values of diabetic retinopathy progression for the assessment of lower limbs and heart muscle perfusion disturbances in patients with diabetes 2

ea0020p401 | Diabetes and Cardiovascular

Association between inflamation markers and metabolic parameters in type 2 diabetic patients, metabolic syndrome, impaired glucose tolerance

ea0020p402 | Diabetes and Cardiovascular

C-reactive protein level early after starting standard treatment of diabetic foot infection is associated with amputation risk

ea0020p403 | Diabetes and Cardiovascular

Use of metformin in pregnancy: a survey of Turkish physicians’ attitudes

ea0020p404 | Diabetes and Cardiovascular

Predictors of amputation in diabetic foot ulcer: single centre experience in a large Turkish cohort

ea0020p405 | Diabetes and Cardiovascular

The prevalence of anemia in Iranian type 2 diabetic patients and the role of nephropathy

ea0020p406 | Diabetes and Cardiovascular

Frequency of hypogonadism in men with type 2 diabetes

ea0020p407 | Diabetes and Cardiovascular

Is testosterone therapy safe for cardiovascular system? The impact of cardiac ultrasound monitoring

ea0020p408 | Diabetes and Cardiovascular

Effects of alteration in serum testosterone levels on beta cell functions in male patients with hypogonadism and in female patients with polycystic ovary syndrome

ea0020p409 | Diabetes and Cardiovascular

Endothelium dependent hemostatic factors and subclinical inflammation in women with previous gestational diabetes mellitus

ea0020p410 | Diabetes and Cardiovascular

Metabolic syndrome and meal stimulated C-peptide levels as useful clinical markers in choosing metformin for combination therapy with sulphonylurea in type 2 diabetic subjects

ea0020p411 | Diabetes and Cardiovascular

Abstract unavailable

ea0020p412 | Diabetes and Cardiovascular

Clinical characteristics and mother-fetal results in patients with gestational diabetes

ea0020p413 | Diabetes and Cardiovascular

Quality of life in diabetes mellitus: conditional issues of treatment and coping strategies

ea0020p414 | Diabetes and Cardiovascular

Thyroid dysfunctions and serum creatine kinase levels in statins-using patients with hyperlipidemia

ea0020p415 | Diabetes and Cardiovascular

Histopatological effects of stress on the heart muscle in rats

ea0020p416 | Diabetes and Cardiovascular

Insulin casts in type 2 patients different shadows with proliferate retinopathy and those with wtent or bypass on coronary rrteries

ea0020p417 | Diabetes and Cardiovascular

Evaluation of the severity of hepatic steatosis in type 2 diabetes

ea0020p418 | Diabetes and Cardiovascular

Microalbuminuria and cardiovascular risk in diabetic patients

ea0020p419 | Diabetes and Cardiovascular

Type 2 diabetes mellitus: failure to recognize cardiovascular risk jeopardizes prevention of diabetes complications in type 2 diabetic patients in daily practice

ea0020p420 | Diabetes and Cardiovascular

Prevalence of diabetic retinopathy and its relation with other risk factors

ea0020p421 | Diabetes and Cardiovascular

Screening of the Romani population in Serbia for diabetes

ea0020p422 | Diabetes and Cardiovascular

Thyrotropin and thyroxine are associated with fasting insulin and insulin resistance in euthyroid impaired glucose tolerant subjects

ea0020p423 | Diabetes and Cardiovascular

The effects of Urtica diocia on rat pancreatic β cell

ea0020p424 | Diabetes and Cardiovascular

Urtica diocia effects on glucose utilization by human muscle cells

ea0020p425 | Diabetes and Cardiovascular

Effects of oral contraceptives versus no treatment on glucose tolerance and patients’ satisfaction during long time follow up in 69 hirsute patients

ea0020p426 | Diabetes and Cardiovascular

The effect of creatinine clearance on the short-term outcome of neuropathic diabetic foot ulcers

ea0020p427 | Diabetes and Cardiovascular

Mean platelet volume in women with previous gestational diabetes and its alteration during pregnancy

ea0020p428 | Diabetes and Cardiovascular

Reduction of major amputations after starting a multidisciplinary diabetic foot care team: single centre experience from Turkey

ea0020p429 | Diabetes and Cardiovascular

Prediction of developing metabolic syndrome after gestational diabetes mellitus

ea0020p430 | Diabetes and Cardiovascular

Exercise induced oxidative stress in type 2 diabetes: relation to diastolic dysfunction and hypertension

ea0020p431 | Diabetes and Cardiovascular

Serum homocysteine levels in diabetes and its relationship to nephropathy

ea0020p432 | Diabetes and Cardiovascular

Can testosterone therapy be included into diabetes treatment in men with metabolic syndrome and hypogonadism?

ea0020p433 | Diabetes and Cardiovascular

The effect of telmisartan and irbesartan treatments on insulin resistance of patients with type 2 diabetes and hypertension

ea0020p434 | Diabetes and Cardiovascular

Insulin treatment intensification in daily diabetes hospital

ea0020p435 | Diabetes and Cardiovascular

Welfare activity in day diabetes hospital in our area: our experience in 2007

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more